We kick off our annual Year in Preview series with a comprehensive look at health care fraud enforcement in 2025. This post proceeds in three parts. First, we explore what the second Trump administration might bring, looking...more
1/13/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Enforcement ,
Enforcement Actions ,
False Claims Act (FCA) ,
Food and Drug Administration (FDA) ,
Fraud ,
Healthcare Fraud ,
Medicare ,
Medicare Advantage ,
White Collar Crimes
The government had another busy year in 2023, investigating and prosecuting healthcare fraud cases on multiple fronts. Contending with the enormous healthcare crises of the now-concluded COVID-19 pandemic and the ongoing...more
7/3/2024
/ Anti-Corruption ,
BlackRock ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Educational Institutions ,
Enforcement ,
Enforcement Actions ,
Export Controls ,
False Claims Act (FCA) ,
Foreign Corrupt Practices Act (FCPA) ,
Fraud ,
Healthcare Fraud ,
Sanctions ,
Securities and Exchange Commission (SEC) ,
Tennessee
This is the sixth in our 2024 Year in Preview series examining important trends in white collar law and investigations in the coming year. We will be posting further installments in the series throughout the next several...more
3/8/2024
/ China ,
Corporate Governance ,
Critical Infrastructure Sectors ,
Drug Pricing ,
Educational Institutions ,
Energy Projects ,
Environmental Social & Governance (ESG) ,
Healthcare ,
Legislative Agendas ,
Medicare Advantage ,
New Legislation ,
New Regulations ,
Pharmaceutical Industry ,
Private Equity ,
Regulatory Agenda ,
Social Media ,
Supply Chain ,
Supply Shortages ,
White Collar Crimes
Congressional Activity -
The challenges around addressing health concerns related to per- and polyfluoroalkyl substances (PFAS) are immense. The Environmental Protection Agency (EPA) states that PFAS are widely used, long...more
This is the fourth part in our 2023 series examining important trends in white collar law and investigations. Up next: SEC.
Last year, as we laid out the landscape for congressional investigations in 2022, we noted that...more
2/23/2023
/ China ,
Competition ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Corporate Counsel ,
Environmental Social & Governance (ESG) ,
Government Entities ,
Inflation Reduction Act (IRA) ,
Infrastructure Investment and Jobs Act (IIJA) ,
Investigations ,
Private Sector ,
Technology Sector ,
Vaccinations ,
White Collar Crimes
Earlier this week, the Southern District of New York dismissed bribery and honest services wire fraud charges brought against New York’s former lieutenant governor, Brian Benjamin, based upon the Indictment’s failure to...more
12/12/2022
/ Bribery ,
Campaign Contributions ,
Campaign Funds ,
Criminal Convictions ,
Fraud ,
Indictments ,
Motion to Dismiss ,
New York ,
Public Corruption ,
Quid Pro Quo ,
Wire Fraud
This is the tenth and final post in this year’s series examining important trends in white collar law and investigations. Be on the lookout for a roundup of our 2022 White Collar Year in Preview Series shortly....more
3/17/2022
/ Big Tech ,
Climate Change ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
Cost-of-Living Adjustment (COLA) ,
Cryptocurrency ,
Drug Pricing ,
Financial Services Industry ,
Healthcare ,
Legislative Agendas ,
Organ Transplant Centers ,
Social Media ,
Special Purpose Acquisition Companies (SPACs) ,
Technology Sector ,
White Collar Crimes